Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Adalimumab + Methotrexate Effective for Uveitis in JIA

  |  

Dr. Ramanan and collaborators responded that, in pediatric care, oral methotrexate may occasionally be used when the child lacks the ability to cope with weekly subcutaneous injections. “In our trial, we did not specify that children had to be receiving methotrexate subcutaneously in order to avoid restricting our ability to enroll participants and in view of issues of acceptability regarding the subcutaneous route in some children,” they write in correspondence to the editor. “We did not undertake pharmacokinetic studies of either methotrexate or adalimumab in this trial.”

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017 Apr 27;376(17):1637–1646. doi: 10.1056/NEJMoa1614160.
  2. Thorne JE. Adalimumab in the treatment of uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017 Apr 27;376(17):1682–1683. doi: 10.1056/NEJMe1701811.
  3. Peng S, Sun X, Sun M. Letter to the editor: Adalimumab for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017 Aug 24.

Related Articles

    An Overview of Pediatric, Noninfectious Uveitis

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    Watch Those Eyes

    What you need to know about Uveitis in Rheumatic Diseases

    ARZTSAMUI / shutterstock.com

    Uveitis: A Brief Primer for the Rheumatologist

    Uveitis is an umbrella term for intraocular inflammatory diseases that can lead to vision loss. It’s not just a concern for ophthalmologists. Uveitis occurs in approximately 2–5% of patients with inflammatory bowel disease, 6–9% of patients with psoriatic arthritis and 25% of patients with reactive arthritis. The prevalence may be as high as 33% in…

    New Guideline Recommends Frequent Monitoring & Collaboration for JIA-Associated Uveitis Management

    As soon as pediatric patients are diagnosed with juvenile idiopathic arthritis (JIA), they should also be screened for uveitis, says ophthalmologist Gary Holland, MD. Otherwise, the University of California, Los Angeles, provider says, “Kids who are diagnosed with JIA may not come to an ophthalmologist until they have vision-limiting complications.” Uveitis is the most common…